Jonathan Young - Net Worth and Insider Trading

Jonathan Young Net Worth

The estimated net worth of Jonathan Young is at least $9 Million dollars as of 2024-11-05. Jonathan Young is the COO of Akero Therapeutics Inc and owns about 276,286 shares of Akero Therapeutics Inc (AKRO) stock worth over $9 Million. Details can be seen in Jonathan Young's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jonathan Young has not made any transactions after 2024-11-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jonathan Young

To

Jonathan Young Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jonathan Young owns 1 companies in total, including Akero Therapeutics Inc (AKRO) .

Click here to see the complete history of Jonathan Young’s form 4 insider trades.

Insider Ownership Summary of Jonathan Young

Ticker Comapny Transaction Date Type of Owner
AKRO Akero Therapeutics Inc 2024-10-14 Chief Operating Officer

Jonathan Young Latest Holdings Summary

Jonathan Young currently owns a total of 1 stock. Jonathan Young owns 276,286 shares of Akero Therapeutics Inc (AKRO) as of November 1, 2024, with a value of $9 Million.

Latest Holdings of Jonathan Young

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKRO Akero Therapeutics Inc 2024-11-01 276,286 31.55 8,716,823

Holding Weightings of Jonathan Young


Jonathan Young Form 4 Trading Tracker

According to the SEC Form 4 filings, Jonathan Young has made a total of 27 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 0 buys and 27 sells. The most-recent trade in Akero Therapeutics Inc is the sale of 50,716 shares on November 1, 2024, which brought Jonathan Young around $2 Million.

Insider Trading History of Jonathan Young

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jonathan Young Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jonathan Young Ownership Network

Ownership Network List of Jonathan Young

No Data

Ownership Network Relation of Jonathan Young

Insider Network Chart

Jonathan Young Owned Company Details

What does Akero Therapeutics Inc do?

Who are the key executives at Akero Therapeutics Inc?

Jonathan Young is the Chief Operating Officer of Akero Therapeutics Inc. Other key executives at Akero Therapeutics Inc include director & President & CEO Andrew Cheng , Chief Development Officer Catriona Yale , and Chief Scientific Officer Timothy Rolph .

Akero Therapeutics Inc (AKRO) Insider Trades Summary

Over the past 18 months, Jonathan Young made 18 insider transaction in Akero Therapeutics Inc (AKRO) with a net sale of 171,998. Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 443,502 shares made by Andrew Cheng , a net sale of 140,584 shares made by Catriona Yale , and a net sale of 321,820 shares made by William Richard White .

In summary, during the past 3 months, insiders sold 478,023 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 478,023 shares. During the past 18 months, 1,227,763 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net purchase of 92,237 shares.

Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Akero Therapeutics Inc Insider Transactions

No Available Data

Jonathan Young Mailing Address

Above is the net worth, insider trading, and ownership report for Jonathan Young. You might contact Jonathan Young via mailing address: C/o Akero Therapeutics, Inc., 170 Harbor Way 3rd Fl, South San Francisco Ca 94080.